OTCs Included For First Time In Study Of Link Between Anticholinergics And Dementia
This article was originally published in The Tan Sheet
Executive Summary
The findings “have public health implications for the education of older adults about potential safety risks because some anticholinergics are available as over-the-counter products,” say the researchers in the JAMA Internal Medicine study.
You may also be interested in...
Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
While Opening Dietary Ingredient Portfolio Wider, DuPont Opens Door On Online Supply Store
In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”
Abbott Mass Distributes Rapid COVID-19 Tests, Offers App So Consumers Can Display Test Results
BinaxNOW rapid tests, the size of a credit card with no other equipment required, are sold directly to organizations at $5 each and an at-home version, with use guided through digital links, is available at $25 per test. It can be paired with NAVICA app, allowing consumers to display negative results through a temporary digital health certificate.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: